NCT00270556View on ClinicalTrials.gov

Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

October 31, 2004

Conditions
HIV
Interventions
DRUG

tenofovir disoproxil fumarate

DRUG

Abacavir

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY